Fellowship · Boston, MA
Sponsored by Mass General Brigham
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
The New England journal of medicine · 2024 · 266 citations · Gregory Lewis
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023 · 271 citations · Mandeep Mehra, Erin Coglianese
Transplantation Outcomes with Donor Hearts after Circulatory Death.
The New England journal of medicine · 2023 · 293 citations · Mandeep Mehra
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
JAMA · 2022 · 413 citations · Mandeep Mehra
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Nature medicine · 2021 · 504 citations · Gregory Lewis
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
Lancet (London, England) · 2021 · 356 citations ·
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
Journal of the American College of Cardiology · 2023 · 175 citations · Neal Lakdawala
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
Lancet (London, England) · 2023 · 204 citations · Neal Lakdawala